Skip to main content
. Author manuscript; available in PMC: 2012 Sep 27.
Published in final edited form as: Curr Opin Immunol. 2009 Mar 21;21(2):233–240. doi: 10.1016/j.coi.2009.03.002

Figure 3.

Figure 3

Survival of patients treated with cell transfer therapy in four consecutive clinical trials using increasing regimens of a lymphodepleting preparative regimen prior to adoptive cell transfer (NMA, non-myeloablative chemotherapy; TBI, total body irradiation). The number in parentheses is the number of patients in each trial.